Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma.

Name: Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma.
License: Public Domain

Mannkind Corporation

ClinicalTrials.gov · Datasets · License: Public Domain

advanced melanoma, stage iii and iv melanoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 181758
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.